Skip to main content
. 2020 May 15;9(5):99. doi: 10.3390/biology9050099

Figure 5.

Figure 5

During the submission of the revised manuscrip an incorrect version of this Figure has been submitted, The figure inserted now is as requested by the reviewers. p66Shc is necessary for Rigosertib-mediated tumor cell killing. Representative Western blots demonstrate γH2AX phosphorylation and PARP cleavage in p66Shc-HA-His transiently transfected MCF7 cells treated with Rigosertib (50 μM) or DMSO for 18 h. All experiments have been repeated at least three times with consistent results. A representative blot is shown.